|
Apr 3
|
REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
|
|
Apr 1
|
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
|
|
Apr 1
|
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25
|
|
Mar 29
|
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
|
|
Mar 29
|
Merck & Co., Inc.'s (NYSE:MRK) Intrinsic Value Is Potentially 98% Above Its Share Price
|
|
Mar 28
|
Merck (MRK) Rises Higher Than Market: Key Facts
|
|
Mar 28
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Mar 28
|
How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together
|
|
Mar 28
|
Company News for Mar 28, 2024
|
|
Mar 28
|
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
|
|
Mar 27
|
US STOCKS-Stocks close with gains, led by Dow as investors look for rate insight
|
|
Mar 27
|
US STOCKS-Stocks gain, led by Dow as investors look for rate insight
|
|
Mar 27
|
US STOCKS-Dow leads gains on Wall Street as investors await rate clues
|
|
Mar 27
|
FDA approves Merck treatment for lung disease, potential path to upside
|
|
Mar 27
|
US STOCKS-Dow leads Wall St higher in lean trading week
|
|
Mar 27
|
Merck Drug for Rare Form of High Blood Pressure Gets US Nod
|
|
Mar 27
|
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
|
|
Mar 27
|
US STOCKS-Wall St set to open higher as growth stocks recover
|
|
Mar 27
|
US STOCKS-Futures tick up in thin trading week, Fed commentary in focus
|
|
Mar 26
|
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
|